Last update May 1, 2016
Very Low Risk
We do not have alternatives for فانكوميسين since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
فانكوميسين is Vancomycin in Arabic.Is written in other languages:
فانكوميسين belongs to this group or family:
|Protein Binding||10 - 55||%|
|VD||0.4 - 1||l/Kg|
|T½||4 - 6||hours|
|Relative Dose||4.8 - 6.7||%|
|Ped.Relat.Dose||4.8 - 6.3||%|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Antibacterial glycopeptide drug.
A high molecular weight its a reason to be excreted in clinically non-significant amount into breast milk, much lower than the dose commonly used for infection in newborns and infants.
Its low oral bioavailability hinders the passage toward infant’s plasma from ingested mother’s milk, except in preterm infants and immediate neonatal period, in which the infant may have an increased intestinal permeability.
Take into account the possibility of negative results of bacterial cultures from febrile infants when their mothers are receiving antibiotics.